Latest Breaking News On - Head of global regulatory affairs - Page 1 : comparemela.com

Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr Sandra Milligan to its Board of Directors

Spyre Therapeutics Appoints Accomplished Biopharma Leader Dr Sandra Milligan to its Board of Directors
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Jeffrey albersSandra milliganRussell coxHead of researchAmgen incCompany or spyreAspira women healthHead of global regulatory affairsProduct development regulatory at genentech incPrnewswire spyre therapeutics incDevelopment of organon coInflammatory bowel diseaseAspira womenCameron turtleChief executive officerSenior vice president

Financial Policy & Legal Expert Courtney Robinson Joins Akoya

Financial Policy & Legal Expert Courtney Robinson Joins Akoya
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Paul larussoCourtney robinsonFreddie macConsumer financial protection bureauGeorge mason university centerCounsel for the centerFederal reserve bankAssociation for enterprise opportunityDistrict of columbia department insuranceHead of global regulatory affairsBlock incGlobal regulatoryBusiness wireExecutive branchCapitol hillRepresentatives committee

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy

CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) for the treatment of IgA Nephropathy
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

New zealandDeric dubeThomas hutterEmmanuelle lecomte brissetVifor internationalHead of global regulatory affairsEuropean medicines agencyTravere therapeutics incFresenius medical careCommittee for medicinal products human useUniversity hospitalEuropean commissionEuropean unionIga nephropathyTravere therapeuticsSenior professor

We asked over 50 women space leaders for words of inspiration Here s what they told us

Current leaders across the space industry share wisdom and advice as we reflect on the achievements of women in space during Women s History month.

United statesValentina tereshkovaMartina dimoskaMalak trabelsi loebMelanie stricklanTuana yaziciJane egerton idehenHolly pascalIrene parkerHeather pringleMary jacksonShelli brunswickBeth mosesKelli kedis ogbornRebecca van burkenNicky fox

CSL Vifor and Travere Therapeutics announce sparsentan receives positive CHMP opinion for the treatment of IgA nephropathy

CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that the European Medicines Agency's (EMA) CHMP has recommended approval of sparsentan for the treatment of adults with primary IgAN with a urine protein excretion >1.0 g/day (or urine protein-to-creatinine ratio ≥0.75 g/g). IgAN is a rare kidney disorder and a leading cause of kidney failure. The CHMP opinion provides the basis for the European Commission's final decision regarding CMA for sparsentan. If approved in Europe

New zealandEmmanuelle lecomte brissetFresenius medical careEuropean commissionVifor internationalHead of global regulatory affairsDrug administrationEuropean unionSenior vice presidentGlobal regulatory affairsTravere therapeuticsMarketing authorization applicationOrphan medicinal product designationVifor fresenius medical care renal pharmaIga nephropathyCsl vifor